The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)
Filter results
| Date | Title | |
|---|---|---|
| 13/05/2020 | First quarter 2020 results press release | |
| 14/04/2020 | ROVI signs a co-operation agreement for a clinical trial to study the efficacy and safety of bemiparin in patients hospitalised with pneumonia caused by COVID-19 | |
| 2/04/2020 | ROVI informs on the impact of Covid 19 on the company’s activities | |
| 26/02/2020 | Full year 2019 results press release | |
| 31/01/2020 | ROVI announces the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union |